Using a Contrast-Enhanced Imaging Sequence at 3-Minute Delay in 3-T Magnetic Resonance Imaging for Acute Infarct Evaluation

Objectives:To investigate the performance of a delayed-enhancement (DE) sequence adapted for a 3-minute delay after bolus injection of a contrast media in cardiac magnetic resonance imaging (MRI) in acute reperfused myocardial infarction. Materials and Methods:Sixty-three patients with recent myocardial infarction underwent contrast-enhanced MRI. Sequences of first-pass (FP) perfusion imaging and DE imaging at 3 and 15 minutes were performed at the acute phase. Of these patients, 49 had a follow-up cardiac magnetic resonance examination. Infarct sizes were quantified by 2 experienced users with a 17-segment model at the acute phase (at FP and at 3- and 15-minute delay) and at the chronic phase (at 15 minutes because only fibrous areas hyperenhance late). Areas of hypoenhancement and hyperenhancement were also calculated. Results from the 3-minute imaging sequence at the acute phase were compared with the FP (taking into account dark signal areas), with the 15-minute DE imaging sequence results at the acute phase [taking into account dark signal and hyperenhanced (white plus dark signal) areas] and with the 15-minute DE imaging sequence from the chronic phase (taking into account hyperenhanced areas). Least squares regression and Bland-Altman plots were performed for the comparisons. Results:For the evaluation of hyperenhancement, the comparison between imaging sequence results at 3 minutes versus 15-minute DE at the acute phase (respectively, at the chronic phase) shows a good correlation (r2 = 0.941; respectively r2 = 0.862, at the chronic phase) and the Bland-Altman plot indicates a good concordance (m =−0.43; SD = 2.69; respectively m = 2.76; SD = 3.92); For the evaluation of hypoenhancement, the comparison between imaging sequence results at 3 minutes versus FP (respectively, 15 minutes at the acute phase) also shows a good correlation (r2 = 0.751; respectively r2 = 0.71) and the Bland-Altman plot indicates a good concordance (m = −1.06; SD = 3.34; respectively m = 2.90; SD = 3.11). Finally, the interobserver study provides a very good kappa coefficient (κ = 0.82), and good kappa coefficients from the intraobserver study (κ1 = 0.78 and κ2 = 0.86). Conclusions:The use of a delayed contrast-enhanced sequence adapted for a 3-minute delay after the bolus injection has the potential to obtain quickly reliable information comparable with the perfusion delay at FP and reliable information from the infarct size at 15 minutes and at the chronic phase.

[1]  R. Kim,et al.  Rapid Detection of Myocardial Infarction by Subsecond, Free-Breathing Delayed Contrast-Enhancement Cardiovascular Magnetic Resonance , 2006, Circulation.

[2]  Jacob Cohen A Coefficient of Agreement for Nominal Scales , 1960 .

[3]  Claus D. Claussen,et al.  MR imaging at rest early after myocardial infarction: detection of preserved function in regions with evidence for ischemic injury and non-transmural myocardial infarction , 2003, European Radiology.

[4]  K. Takeda,et al.  Late gadolinium-enhanced magnetic resonance imaging in acute and chronic myocardial infarction. Improved prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium. , 2005, Journal of the American College of Cardiology.

[5]  S. Schoenberg,et al.  Single-shot inversion recovery TrueFISP for assessment of myocardial infarction. , 2006, AJR. American journal of roentgenology.

[6]  E. Atalar,et al.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. , 1995, Circulation.

[7]  J. Gili,et al.  Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. , 1993, Cardiovascular research.

[8]  J. Sandstede Assessment of myocardial viability by MR imaging , 2002, European Radiology.

[9]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[10]  Olga Bondarenko,et al.  Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[11]  O. Simonetti,et al.  "Black blood" T2-weighted inversion-recovery MR imaging of the heart. , 1996, Radiology.

[12]  D Hahn,et al.  Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MR imaging: use in the prediction of myocardial viability. , 2000, AJR. American journal of roentgenology.

[13]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[14]  M. Reiser,et al.  Myocardial Perfusion Imaging With Gadobutrol: A Comparison Between 3 and 1.5 Tesla With an Identical Sequence Design , 2007, Investigative radiology.

[15]  H. Ito No reflow phenomenon in coronary heart disease. , 2001, Journal of cardiology.

[16]  R. Judd,et al.  Assessment of Myocardial Viability by Cardiovascular Magnetic Resonance Imaging , 2022 .

[17]  U. Sechtem,et al.  MRI assessment of myocardial viability: comparison with other imaging techniques. , 1999, Rays.

[18]  M. Lipton,et al.  Imaging of ischemic heart disease , 2002, European Radiology.

[19]  D Revel,et al.  Myocardial “low reflow” assessed by Dy‐DTPA‐BMA‐enhanced first‐pass MR imaging in a dog model , 1999, Journal of magnetic resonance imaging : JMRI.

[20]  Wei Li,et al.  Myocardial delayed enhancement imaging using inversion recovery single‐shot steady‐state free precession: Initial experience , 2004, Journal of magnetic resonance imaging : JMRI.

[21]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[22]  Stephan G Nekolla,et al.  Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. , 2005, Journal of the American College of Cardiology.

[23]  R. Cury,et al.  Utility of cardiovascular magnetic resonance to predict left ventricular recovery after primary percutaneous coronary intervention for patients presenting with acute ST-segment elevation myocardial infarction. , 2007, The American journal of cardiology.

[24]  K. Takeda,et al.  Prediction of regional functional recovery after acute myocardial infarction with low dose dobutamine stress cine MR imaging and contrast enhanced MR imaging. , 2003, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[25]  A. Lalande,et al.  The extent of myocardial damage assessed by contrast‐enhanced MRI is a major determinant of N‐BNP concentration after myocardial infarction , 2004, European journal of heart failure.

[26]  P. Hunold,et al.  [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography]. , 2002, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[27]  K. Takeda,et al.  Diagnostic value of late gadolinium-enhanced MRI and first-pass dynamic MRI for predicting functional recovery in patients after acute myocardial infarction , 2007, Radiation Medicine.

[28]  R. Kim,et al.  Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function , 2001, Circulation.

[29]  O. Simonetti,et al.  An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.

[30]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[31]  A. Lalande,et al.  Automatic Fuzzy Classification of the Washout Curves From Magnetic Resonance First-Pass Perfusion Imaging After Myocardial Infarction , 2005, Investigative radiology.

[32]  Peter Kellman,et al.  Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. , 2004, Journal of the American College of Cardiology.

[33]  B. Schnackenburg,et al.  Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance Imaging: Comparison With Positron Emission Tomography , 2002, Circulation.

[34]  M. Hori,et al.  Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.

[35]  Bernd Hamm,et al.  Myocardial viability: assessment with three-dimensional MR imaging in pigs and patients. , 2006, Radiology.

[36]  S. Schoenberg,et al.  Phase-Sensitive Inversion Recovery (PSIR) Single-Shot TrueFISP for Assessment of Myocardial Infarction at 3 Tesla , 2006, Investigative radiology.

[37]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[38]  A. Lalande,et al.  Visual estimation of the global myocardial extent of hyperenhancement on delayed contrast-enhanced MRI , 2004, European Radiology.

[39]  C. Claussen,et al.  Assessment of Myocardial Viability Using Delayed Enhancement Magnetic Resonance Imaging at 3.0 Tesla , 2006, Investigative radiology.

[40]  R. Kim,et al.  Reproducibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic Resonance Imaging , 2002, Circulation.

[41]  M. Miyagawa,et al.  Evaluation of Acute Myocardial Infarction with Late Enhancement Pattern on MRI Compared with 201Tl and 99mTc-Hydroxymethylenediphosphonate (HMDP) Dual Single Photon Emission Computed Tomography (SPECT) Images , 2007, Investigative radiology.

[42]  R O Bonow,et al.  Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. , 1998, Circulation.

[43]  J. Finn,et al.  Cardiac MR imaging: state of the technology. , 2006, Radiology.

[44]  Katherine C. Wu,et al.  Accuracy of Contrast-Enhanced Magnetic Resonance Imaging in Predicting Improvement of Regional Myocardial Function in Patients After Acute Myocardial Infarction , 2002, Circulation.

[45]  A. Beek,et al.  Myocardial viability: rapid assessment with delayed contrast-enhanced MR imaging with three-dimensional inversion-recovery prepared pulse sequence. , 2004, Radiology.

[46]  A. Roos,et al.  Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. , 1998, American heart journal.

[47]  Bernd Hamm,et al.  3D and 2D delayed-enhancement magnetic resonance imaging for detection of myocardial infarction: preclinical and clinical results. , 2007, Academic radiology.

[48]  M. Reiser,et al.  Inversion Recovery Single-Shot TurboFLASH for Assessment of Myocardial Infarction at 3 Tesla , 2007, Investigative radiology.

[49]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[50]  Gerhard Adam,et al.  Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. , 2004, Radiology.

[51]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.

[52]  Andrew C Larson,et al.  Motion‐corrected free‐breathing delayed enhancement imaging of myocardial infarction , 2005, Magnetic resonance in medicine.